About Dylan Sammut
Articles Written by Dylan Sammut
Pharmaceutical Firms Are Cleaning House to Profit
There’s no doubt it was an unusually slow February in the healthcare M&A market. Historically, the middle of Q1 tends to dip and then rebound by March, but with less than 100 deals on the books, the rapid spread of the coronavirus, Covid-19, seems to have... Read More »
Physician Group Merger Creates Florida’s Largest Orthopaedic Provider
February was a modest month for Physician Medical Group deals. With seven on the books thus far (we expect more to pop up), it beat February 2019’s total by just one deal. However, M&A activity seems to be gaining steam in March, with a number of deals... Read More »
Health Care M&A Deals, March 6, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most... Read More »
Genentech Bets on Bicycle-Based Therapies
Genentech, a subsidiary of the Roche Group (OTCMKTS: RHHBY), is betting big on a collaboration effort with Bicycle Therapeutics plc (NASDAQ: BCYC). The exclusive collaboration agreement between the two biotechnology companies hopes to develop and commercialize... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
